Ascentage Pharma Group International
ASPHFOTCHealthcare● Active
$4.53
$-0.17(-3.51%)
Market Cap$1.7B
P/E Ratio—
52W High$10.65
52W Low$4.53
Ascentage Pharma Group International（ASPHF）· 损益表
年度 / 季度 / TTM 视图 · SEC 10-K 与 10-Q（经 FMP 聚合）· 可在下方切换周期与 M/B/T 单位。
FMP · ASPHF · 截至 2026-06-08
财务报表
Revenue · Gross Profit · Net Income
| Breakdown | 2025-12 | 2024-12 | 2023-12 | 2022-12 | 2021-12 |
|---|---|---|---|---|---|
| Revenue | |||||
| Revenue | $0.56B | $0.98B | $0.22B | $0.21B | $0.03B |
| Cost of Revenue | $0.13B | $0.03B | $0.03B | $0.02B | $0.00B |
| Gross Profit | $0.43B | $0.95B | $0.19B | $0.19B | $0.02B |
| Gross Margin %(computed) | 76.41% | 97.03% | 86.24% | 89.51% | 88.08% |
| Operating Expenses | |||||
| R&D Expenses | $1.08B | $0.95B | $0.71B | $0.74B | $0.77B |
| G&A Expenses | $0.00B | $0.19B | $0.18B | $0.17B | $0.14B |
| Total Operating Expenses | $1.61B | $1.32B | $1.06B | $1.03B | $0.85B |
| Operating Income | ($1.18B) | ($0.37B) | ($0.87B) | ($0.88B) | ($0.93B) |
| Operating Margin %(computed) | -211.14% | -37.70% | -393.11% | -421.25% | — |
| Interest Income | $0.08B | $0.04B | $0.03B | $0.01B | $0.01B |
| Interest Expense | $0.05B | $0.06B | $0.10B | $0.05B | $0.02B |
| Income Before Tax | ($1.20B) | ($0.40B) | ($0.93B) | ($0.89B) | ($0.83B) |
| Income Tax Expense | $0.01B | $0.01B | ($0.01B) | ($0.00B) | ($0.05B) |
| Net Income | ($1.21B) | ($0.41B) | ($0.93B) | ($0.88B) | ($0.78B) |
| Net Margin %(computed) | -216.47% | -41.34% | -416.98% | -421.02% | — |
| Per Share & EBITDA | |||||
| EPS (Basic) | $-3.43 | $-1.37 | $-3.28 | $-3.35 | $-3.07 |
| Wtd Avg Shares | 0.36B | 0.30B | 0.28B | 0.26B | 0.25B |
| EBITDA | ($1.10B) | ($0.24B) | ($0.74B) | ($0.84B) | ($0.92B) |
| EBITDA Margin %(computed) | -196.08% | -24.23% | -334.98% | -398.64% | — |
数据来源：Financial Modeling Prep · 最后更新：2026-06-08 · CNY · B
深入了解Ascentage Pharma Group International
关于Ascentage Pharma Group International（ASPHF）损益表
Ascentage Pharma Group International（ASPHF）损益表数据来源于SEC Form 10-K及10-Q申报文件。2025财年，ASPHF实现营收$0.56B，毛利润$0.43B（毛利率76.41%），净利润($1.21B)（净利率-216.47%）。
常见问题
ASPHF · 4 问Ascentage Pharma Group International（ASPHF）2025财年营收为$0.56B，同比down43.0%。
ASPHF revenueASPHF salesannual revenue YoYincome statement
· Source: FMP /stable/income-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-08